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Background: Quality of Life (QoL) is an important consequence in neurological 
clinical care. The debate about generic and disease specific measures of quality of 
life reflects uncertainty about whether there are unique aspects to understanding 
QoL in different diseases. If there are commonalities to different disabling 
neurological diseases, it may be credible to extrapolate from more common and 
better-studied conditions, like multiple sclerosis (MS) to rarer diseases like motor 
neurone disease (MND). Distinctions across neurological conditions would suggest 
that strategies to maximise QoL must be disease specific. 
 
Objectives: In this analysis our aim was to explore psychosocial factors affecting QoL 
in MND in comparison with MS. 
 
Methods: The study employed both semi-structured interviews and focus groups. 
Each focus group was consisted of either MND or MS. All interviews and group 
discussions were audio recorded and transcribed verbatim for a thematic analysis. 
Themes were inductively developed within a condition before they were compared 
across the two conditions for cross-sectional exploration.  
 
Results: Data was collected from 40 people with MND: 26 interviews (male=14; 
mean age= 64yrs; mean illness duration=1.6yrs); 14 in focus groups (male=9; mean 
age=62yrs; mean illness duration=3.5yrs); and from 61 people with MS: 43 
interviews (male=16; mean age=52yrs; mean illness duration=15yrs); 18 in focus 
groups (male=6; mean age=47yrs; mean illness duration=9yrs). A codebook for each 
condition was developed for the analysis and saturation was achieved in both MND 
and MS.  
Whilst the analysis identified the same psychosocial domains to be important for 
QoL irrespective of disease, there was an aspect unique to MND of it being a 
terminal condition. Both MS and MND patients valued their lives, but MND patients 
recognised their shorter life expectancy and differed from MS patients because 
thoughts of imminent death adversely impacted QoL. Participant’s concerns about 
their death were not restricted to themselves, but extended to impact on significant 
others. The differences between MND and MS were further observed with regard to 
factors that were beneficial to QoL. Although the positive influence of environmental 
factors and spirituality were found in both conditions, additional implications of 
these factors were found amongst the MND group: it was found that the importance 
of environment included the place of death, and spirituality was described to provide 
hope even beyond death.  
 
Discussion and conclusions: The current study reveals complexity in ascertaining QoL 
across neurological diseases. Despite distinct illness trajectories, the same 
psychosocial factors were identified to be important for QoL in MND and MS. 
Nevertheless, MND as a terminal condition was found to further challenge patient’s 
QoL. The findings confirm the importance of addressing this aspect of the condition in 
addition to commonly investigated psychosocial factors.  
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